Filing Details

Accession Number:
0001209191-21-029378
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-30 13:00:00
Reporting Period:
2021-04-28
Accepted Time:
2021-04-30 19:57:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1796280 Oric Pharmaceuticals Inc. ORIC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1214133 H Richard Scheller C/O Oric Pharmaceuticals, Inc.
240 E. Grand Ave., 2Nd Floor
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-04-28 200 $25.11 49,600 No 4 S Direct
Common Stock Disposition 2021-04-30 100 $25.19 49,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.